12 March 2008
Immtech Announces Update On Business Operations
22 February 2008
Immtech Focusing on New Infectious Disease Programs Following Discontinuation Of Development For Pafuramidine
19 February 2008
Immtech Investor Conference Call Scheduled For February 22, 2008
13 February 2008
Immtech Appoints Blythe Weigh As Strategic Advisor
11 February 2008
Immtech Reports Fiscal Third Quarter 2008 Results
06 February 2008
Immtech Investor Conference Call Scheduled for February 11, 2008
28 December 2007
Immtech Investor Conference Call Scheduled for January 3, 2008, at 1 PM
26 December 2007
Immtech Announces Pafuramidine (DB289) Program on Clinical Hold
05 December 2007
Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine
管理队伍
Eric L. Sorkin
主席及行政总裁
Cecilia Chan
副主席
Gary C. Parks
公司秘书、司库及财务总监
Carol Ann Olson, M.D., PhD
医药开发部门高级副总裁及医学总监
Norman A. Abood, PhD
高级副总裁 , 项目发展部
Daniel M. Schmitt
高级副总裁 , 专利项目及商务发展部
